Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metformin in Head and Neck Cancer
NCT03109873Phase 1Completed
- Sponsor
- Sidney Kimmel Comprehensive Cancer Center
- Start
- Jan 2017
- Primary completion
- Jul 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of liquid metformin (Aspargo Labs) in head and neck cancer (HNC) (2 arms), sponsored by Sidney Kimmel Comprehensive Cancer Center. Primary endpoint: Cytokine/Chemokine Profile up to 1 year. Started Jan 2017; status: completed.
02
Drugs
liquid metformin (Aspargo Labs)
03
Conditions
head and neck cancer (HNC)
Beyond the preview
Go deeper on NCT03109873.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03109873.